Global Anti-CD20 Monoclonal Antibodies Market Size, Share, Trends and Forecast 2020-2026

Description

Anti-CD20 monoclonal antibody is an anti-tumor agent for the treatment of non-hodge B cell malignancy.Unlike conventional treatments, these antibodies attack the CD20 antigen on cancer cells.
The global Anti-CD20 Monoclonal Antibodies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
This report focuses on Anti-CD20 Monoclonal Antibodies volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-CD20 Monoclonal Antibodies market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Anti-CD20 Monoclonal Antibodies Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Anti-CD20 Monoclonal Antibodies Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Anti-CD20 Monoclonal Antibodies Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
First Generation Anti-CD20 Monoclonal Antibody
Second Generation Anti-CD20 Monoclonal Antibody
Third Generation Anti-CD20 Monoclonal Antibody
By Application:
Oncology
Neurology
Immunology
Key Players:
The Key manufacturers that are operating in the global Anti-CD20 Monoclonal Antibodies market are:
Genmab
Amgen
Celltrion
Roche
Novartis AG
Pfizer
Biogen
Genentech
Immunomedics
Spectrum Pharmaceuticals
Bio-Rad Laboratories
LFB Biotechnologie
Competitive Landscape
The analysts have provided a comprehensive analysis of the competitive landscape of the global Anti-CD20 Monoclonal Antibodies market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

TABLE OF CONTENT

1 Anti-CD20 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Anti-CD20 Monoclonal Antibodies
1.2 Anti-CD20 Monoclonal Antibodies Segment by Type
1.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Anti-CD20 Monoclonal Antibodies Segment by Application
1.3.1 Anti-CD20 Monoclonal Antibodies Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Global Anti-CD20 Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Anti-CD20 Monoclonal Antibodies Revenue 2015-2026
1.4.2 Global Anti-CD20 Monoclonal Antibodies Sales 2015-2026
1.4.3 Anti-CD20 Monoclonal Antibodies Market Size by Region: 2020 Versus 2026
1.5 Anti-CD20 Monoclonal Antibodies Industry
1.6 Anti-CD20 Monoclonal Antibodies Market Trends

2 Global Anti-CD20 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-CD20 Monoclonal Antibodies Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-CD20 Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
2.5 Anti-CD20 Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Anti-CD20 Monoclonal Antibodies Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-CD20 Monoclonal Antibodies Players (Opinion Leaders)

3 Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.3.1 North America Anti-CD20 Monoclonal Antibodies Sales by Country
3.3.2 North America Anti-CD20 Monoclonal Antibodies Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Country
3.4.2 Europe Anti-CD20 Monoclonal Antibodies Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region
3.5.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country
3.6.2 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country
3.7.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-CD20 Monoclonal Antibodies Historic Market Analysis by Type
4.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
4.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
4.3 Global Anti-CD20 Monoclonal Antibodies Price Market Share by Type (2015-2020)
4.4 Global Anti-CD20 Monoclonal Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Anti-CD20 Monoclonal Antibodies Historic Market Analysis by Application
5.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
5.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
5.3 Global Anti-CD20 Monoclonal Antibodies Price by Application (2015-2020)

6 Company Profiles and Key Figures in Anti-CD20 Monoclonal Antibodies Business
6.1 Genmab
6.1.1 Corporation Information
6.1.2 Genmab Description, Business Overview and Total Revenue
6.1.3 Genmab Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Genmab Products Offered
6.1.5 Genmab Recent Development
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description, Business Overview and Total Revenue
6.2.3 Amgen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Amgen Products Offered
6.2.5 Amgen Recent Development
6.3 Celltrion
6.3.1 Celltrion Corporation Information
6.3.2 Celltrion Description, Business Overview and Total Revenue
6.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Celltrion Products Offered
6.3.5 Celltrion Recent Development
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description, Business Overview and Total Revenue
6.4.3 Roche Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Roche Products Offered
6.4.5 Roche Recent Development
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description, Business Overview and Total Revenue
6.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Novartis AG Products Offered
6.5.5 Novartis AG Recent Development
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description, Business Overview and Total Revenue
6.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Pfizer Products Offered
6.6.5 Pfizer Recent Development
6.7 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description, Business Overview and Total Revenue
6.6.3 Biogen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Biogen Products Offered
6.7.5 Biogen Recent Development
6.8 Genentech
6.8.1 Genentech Corporation Information
6.8.2 Genentech Description, Business Overview and Total Revenue
6.8.3 Genentech Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Genentech Products Offered
6.8.5 Genentech Recent Development
6.9 Immunomedics
6.9.1 Immunomedics Corporation Information
6.9.2 Immunomedics Description, Business Overview and Total Revenue
6.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Immunomedics Products Offered
6.9.5 Immunomedics Recent Development
6.10 Spectrum Pharmaceuticals
6.10.1 Spectrum Pharmaceuticals Corporation Information
6.10.2 Spectrum Pharmaceuticals Description, Business Overview and Total Revenue
6.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Spectrum Pharmaceuticals Products Offered
6.10.5 Spectrum Pharmaceuticals Recent Development
6.11 Bio-Rad Laboratories
6.11.1 Bio-Rad Laboratories Corporation Information
6.11.2 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Bio-Rad Laboratories Products Offered
6.11.5 Bio-Rad Laboratories Recent Development
6.12 LFB Biotechnologie
6.12.1 LFB Biotechnologie Corporation Information
6.12.2 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.12.4 LFB Biotechnologie Products Offered
6.12.5 LFB Biotechnologie Recent Development

7 Anti-CD20 Monoclonal Antibodies Manufacturing Cost Analysis
7.1 Anti-CD20 Monoclonal Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
7.4 Anti-CD20 Monoclonal Antibodies Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-CD20 Monoclonal Antibodies Distributors List
8.3 Anti-CD20 Monoclonal Antibodies Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-CD20 Monoclonal Antibodies by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-CD20 Monoclonal Antibodies by Type (2021-2026)
10.2 Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-CD20 Monoclonal Antibodies by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-CD20 Monoclonal Antibodies by Application (2021-2026)
10.3 Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-CD20 Monoclonal Antibodies by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-CD20 Monoclonal Antibodies by Region (2021-2026)
10.4 North America Anti-CD20 Monoclonal Antibodies Estimates and Projections (2021-2026)
10.5 Europe Anti-CD20 Monoclonal Antibodies Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-CD20 Monoclonal Antibodies Estimates and Projections (2021-2026)
10.7 Latin America Anti-CD20 Monoclonal Antibodies Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-CD20 Monoclonal Antibodies Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample